Physician profile
Chris Stephen Mcclellan
NPI 1801991096
$32,818.81
in general payments reported to CMS, 2019-2025
16 companies · $8,014 in 2025
The $8,014 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $5,311 · 2021: $19K · 2022: $161 · 2023: $241 · 2024: $342 · 2025: $8,014.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,330 · Consulting Fee: $2,750 · Travel and Lodging: $2,516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,330.16 |
| Consulting Fee | $2,750.00 |
| Travel and Lodging | $2,516.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corentec America INC | $28,748.10 | 2020-2025 | Corentec |
| Zimmer Biomet Holdings, INC. | $2,956.66 | 2025 | Persona, G7 |
| Amgen INC. | $274.44 | 2024 | Evenity, Prolia |
| Nevro Corp. | $129.41 | 2023 | Senza |
| Innovation Technologies INC | $126.98 | 2021 | |
| Ethicon US, LLC | $111.64 | 2021 | |
| Smith+Nephew, INC. | $98.14 | 2019-2025 | Pico, Pico 7 |
| Stryker Corporation | $96.82 | 2019-2022 | |
| Davol INC. | $83.36 | 2021-2023 | Arista Ah Flexitip, Progel Applicator Spray Tips |
| Ferring Pharmaceuticals INC. | $44.14 | 2022-2024 | Euflexxa |
| Horizon Therapeutics Plc | $35.48 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $34.62 | 2025 | |
| Depuy Synthes Sales INC. | $28.09 | 2023-2024 | Monovisc, Orthovisc |
| Medtronic USA, INC. | $17.97 | 2019 | |
| Endo Pharmaceuticals INC. | $17.96 | 2023 | Xiaflex |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $15.00 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Mcclellan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.